Malignant hyperthermia: a pharmacogenetic disorder

Orthopedics. 2009 Nov;32(11):835. doi: 10.3928/01477447-20090922-18.
No abstract available

Publication types

  • Review

MeSH terms

  • Dantrolene / therapeutic use
  • Genetic Predisposition to Disease
  • Humans
  • Malignant Hyperthermia / genetics*
  • Malignant Hyperthermia / physiopathology*
  • Malignant Hyperthermia / therapy
  • Muscle Relaxants, Central / therapeutic use
  • Mutation
  • Ryanodine Receptor Calcium Release Channel / genetics*
  • Syndrome

Substances

  • Muscle Relaxants, Central
  • Ryanodine Receptor Calcium Release Channel
  • Dantrolene